Literature DB >> 12794413

Comparison of procalcitonin and C-reactive protein as markers of sepsis.

Aldo Luzzani1, Enrico Polati, Romolo Dorizzi, Alessio Rungatscher, Raffaella Pavan, Alberto Merlini.   

Abstract

OBJECTIVE: To compare the clinical informative value of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations in the detection of infection and sepsis and in the assessment of severity of sepsis.
DESIGN: Prospective study.
SETTING: Medicosurgical intensive care unit. PATIENTS: Seventy consecutive adult patients who were admitted to the intensive care unit for an expected stay >24 hrs.
INTERVENTIONS: None. MEASUREMENTS: PCT and CRP plasma concentrations were measured daily during the intensive care unit stay. Each patient was examined daily for signs and symptoms of infection and was classified daily in one of the following four categories according to the American College of Chest Physicians/Society of Critical Care Medicine criteria: negative, systemic inflammatory response syndrome, localized infection, and sepsis group (sepsis, severe sepsis, or septic shock). The severity of sepsis-related organ failure was assessed by the sepsis-related organ failure assessment score. MAIN
RESULTS: A total of 800 patient days were classified into the four categories. The median plasma PCT concentrations in noninfected (systemic inflammatory response syndrome) and localized-infection patient days were 0.4 and 1.4 ng/mL (p <.0001), respectively; the median CRP plasma concentrations were 79.9 and 85.3 mg/L (p =.08), respectively. The area under the receiver operating characteristic curve was 0.756 for PCT (95% confidence interval [CI], 0.675-0.836), compared with 0.580 for CRP (95% CI, 0.488-0.672) (p <.01). The median plasma PCT concentrations in nonseptic (systemic inflammatory response syndrome) and septic (sepsis, severe sepsis, or septic shock) patient days were 0.4 and 3.65 ng/mL (p <.0001), respectively, whereas those for CRP were 79.9 and 115.6 mg/L (p <.0001), respectively. The area under the receiver operating characteristic curve was 0.925 for PCT (95% CI, 0.899-0.952), compared with 0.677 for CRP (95% CI, 0.622-0.733) (p <.0001). The linear correlation between PCT plasma concentrations and the four categories was much stronger than in the case of CRP (Spearman's rho, 0.73 vs. 0.41; p <.05). A rise in sepsis-related organ failure assessment score was related to a higher median value of PCT but not CRP.
CONCLUSION: PCT is a better marker of sepsis than CRP. The course of PCT shows a closer correlation than that of CRP with the severity of infection and organ dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794413     DOI: 10.1097/01.CCM.0000063440.19188.ED

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  104 in total

Review 1.  Persistent systemic inflammation in chronic critical illness.

Authors:  Christopher E Cox
Journal:  Respir Care       Date:  2012-06       Impact factor: 2.258

Review 2.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

Review 3.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

4.  Altered levels of soluble CD18 may associate immune mechanisms with outcome in sepsis.

Authors:  T W Kragstrup; K Juul-Madsen; S H Christiansen; X Zhang; J Krog; T Vorup-Jensen; A G Kjaergaard
Journal:  Clin Exp Immunol       Date:  2017-08-07       Impact factor: 4.330

5.  In vivo demonstration of neuroinflammatory molecule expression in brain abscess with diffusion tensor imaging.

Authors:  R K Gupta; K Nath; A Prasad; K N Prasad; M Husain; R K S Rathore; N Husain; C Srivastava; P Khetan; R Trivedi; P A Narayana
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

Review 6.  Sepsis: a clinical update.

Authors:  Corey E Ventetuolo; Mitchell M Levy
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-07       Impact factor: 8.237

Review 7.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

8.  Determination of Factors Affecting Mortality of Patients with Sepsis in a Tertiary Intensive Care Unit.

Authors:  Baran Balcan; Şehnaz Olgun; Fatih Torlak; Seda Beyhan Sağmen; Emel Eryüksel; Sait Karakurt
Journal:  Turk Thorac J       Date:  2015-07-01

9.  Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.

Authors:  David T Huang; Lisa A Weissfeld; John A Kellum; Donald M Yealy; Lan Kong; Michael Martino; Derek C Angus
Journal:  Ann Emerg Med       Date:  2008-03-17       Impact factor: 5.721

Review 10.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.